Glickman Richard M
SEC CIK 1352637 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENGN | enGene Therapeutics Inc. | Dir | 24.7K | — | — | 2 | 2023-10-31 | 2024-05-28 |
Most active insiders at ENGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grossman William | Interim Chief Medical Off, Dir | $10.1K | — |
Glickman Richard M made no open-market trades at ENGN in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-29 | 2024-05-28 | ENGN | enGene Therapeutics Inc. | Glickman Richard M | Dir | M - OptEx | $0.89 | +120 | 24.7K | +0.5% | +$106.80 |
| D | 2023-11-02 | 2023-10-31 | ENGN | enGene Therapeutics Inc. | Glickman Richard M | Dir | A - Grant | — | +24.6K | 24.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations